Susceptibility to primary sclerosing cholangitis is associated with a polymorphism of the MMP-9 (gelatinase B) gene

Susceptibility to primary sclerosing cholangitis is associated with a polymorphism of the MMP-9 (gelatinase B) gene

Detalhes bibliográficos
Principais autores:	Cullen, SN, Jewell, D, Chapman, R
Formato:	Journal article
Publicado em:	2002

Registros relacionados

Association between genetic polymorphism in matrix metalloproteinase 2 (MMP-2, gelatinase A) and susceptibility to primary sclerosing cholangitis
por: Cullen, SN, et al.
Publicado em: (2003)

No association between Nod2 polymorphisms and susceptibility to, or progression of, primary sclerosing cholangitis
por: Cullen, SN, et al.
Publicado em: (2002)

Susceptibility to primary sclerosing cholangitis is associated with polymorphisms of intercellular adhesion molecule-1.
por: Yang, X, et al.
Publicado em: (2004)

A functional polymorphism of the stromelysin gene (MMP-3) influences susceptibility to primary sclerosing cholangitis.
por: Satsangi, J, et al.
Publicado em: (2001)

The medical management of primary sclerosing cholangitis.
por: Cullen, SN, et al.
Publicado em: (2006)

A regulatory polymorphism of the stromelysin gene (MMP-3) strongly influences susceptibility to primary sclerosing cholangitis (PSC) and progression to portal hypertension.
por: Satsangi, J, et al.
Publicado em: (2000)

Primary sclerosing cholangitis.
por: Cullen, S, et al.
Publicado em: (2003)

Tumour necrosis factor alpha (TNF) gene haplotypes and primary sclerosing cholangitis
por: Cullen, SN, et al.
Publicado em: (2003)

Review article: current management of primary sclerosing cholangitis.
por: Cullen, SN, et al.
Publicado em: (2005)

Etiopathogenesis of primary sclerosing cholangitis.
por: Chapman, R, et al.
Publicado em: (2008)

Aetiopathogenesis of primary sclerosing cholangitis.
por: Cullen, S, et al.
Publicado em: (2001)

Immunopathogenesis of primary sclerosing cholangitis.
por: Worthington, J, et al.
Publicado em: (2005)

Primary sclerosing cholangitis--an immunologically mediated disease?
por: Chapman, R, et al.
Publicado em: (1985)

Primary sclerosing cholangitis
por: Chapman, R
Publicado em: (2007)

Primary sclerosing cholangitis.
por: Chapman, R
Publicado em: (1985)

Primary sclerosing cholangitis.
por: Mitchell, SA, et al.
Publicado em: (2000)

Primary sclerosing cholangitis.
por: Williamson, K, et al.
Publicado em: (2014)

Primary sclerosing cholangitis.
por: Worthington, J, et al.
Publicado em: (2006)

Primary sclerosing cholangitis
por: Chapman Roger, et al.
Publicado em: (2006-10-01)

The management of primary sclerosing cholangitis.
por: Chapman, R
Publicado em: (2003)

The immunology of primary sclerosing cholangitis.
por: Chapman, R
Publicado em: (1990)

Primary sclerosing cholangitis - Foreword
por: Chapman, R
Publicado em: (2006)

THE IMMUNOGENETICS OF PRIMARY SCLEROSING CHOLANGITIS
por: Chapman, R
Publicado em: (1993)

Deposition of complement C 9 in primary sclerosing cholangitis.
por: Shanahan, J, et al.
Publicado em: (1998)

Mapping MHC-encoded susceptibility and resistance in primary sclerosing cholangitis: the role of MICA polymorphism.
por: Norris, S, et al.
Publicado em: (2001)

An update on primary sclerosing cholangitis.
por: Maggs, JR, et al.
Publicado em: (2008)

The management of primary sclerosing cholangitis.
por: Mitchell, SA, et al.
Publicado em: (1998)

High dose ursodeoxycholic acid for the treatment of primary sclerosing cholangitis is safe and effective
por: Cullen, SN, et al.
Publicado em: (2006)

Serum autoantibodies, ulcerative colitis and primary sclerosing cholangitis
por: Chapman, R, et al.
Publicado em: (1986)

Serum autoantibodies, ulcerative colitis and primary sclerosing cholangitis.
por: Chapman, R, et al.
Publicado em: (1986)

PORTAL TRACT LYMPHOCYTE POPULATIONS IN PRIMARY SCLEROSING CHOLANGITIS
por: Snook, J, et al.
Publicado em: (1987)

Deposition of complement C9 in primary sclerosing cholangitis (PSC).
por: Shanahan, J, et al.
Publicado em: (1998)

Small duct primary sclerosing cholangitis.
por: Chapman, R
Publicado em: (2002)

MEDICAL TREATMENT OF PRIMARY SCLEROSING CHOLANGITIS
por: Chapman, R
Publicado em: (1994)

High dose ursodeoxycholic acid for the treatment of primary sclerosing cholangitis is safe and effective.
por: Cullen, SN, et al.
Publicado em: (2008)

Chemoprevention and screening in primary sclerosing cholangitis.
por: Kitiyakara, T, et al.
Publicado em: (2008)

Liver transplantation for primary sclerosing cholangitis.
por: Gow, P, et al.
Publicado em: (2000)

Synergistic effect of collagenase-1 (MMP1), stromelysin-1 (MMP3) and gelatinase-B (MMP9) gene polymorphisms in breast cancer.
por: Chiranjeevi Padala, et al.
Publicado em: (2017-01-01)

Sclerosing cholangitis
por: Martins, E, et al.
Publicado em: (1998)

Sclerosing cholangitis
por: Martins, E, et al.
Publicado em: (1997)